impact factor
logo
 

Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.

Annual Supplements

In addition to regular issues, it also publishes a number of annual supplements dedicated to the following topics:

Starting in 2022 a new annual issue on Myositis will be published. This monothematic issue will also be the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics are processed with the same peer-review criteria as those published in the regular issues. Once accepted, they are published ahead-of-print online, and subsequently included in the correspondent supplement issue, unless otherwise expressly requested by the Authors.

Articles published in the supplements share the same citation coverage and impact factor as the main journal (PubMed, Scopus, Science Citation Index, etc.).

Editor-in-Chief
Stefano Bombardieri, MD

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €100.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

The 5 most viewed PDFs in the last 7 days
in press from 6 month ago (One year in review excluded)

From 21/11/2021 to 28/11/2021

CER14432
Free to view
31 click

Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis
M. Romano, V. Gerloni, O. De Lucia, D. Piskin, T. Giani, M. Gattinara, M.O. Borghi, C. Bodio, M. Mahler, P.L. Meroni, R. Cimaz

Rheumatology Abstract

 

CER15077
Free to view
22 click

How to classify PFAPA? No hard evidence for associated CAPS or CARD variants and not any for links with Behçet’s syndrome
E. Ben-Chetrit, H. Yazici

Rheumatology Abstract

 

CER14837
Free to view
17 click

Apremilast for oral ulcers associated with active Behçet’s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici

Rheumatology Abstract

 

CER14985
Free to view
16 click

Flare-up of adult-onset Still’s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota

Rheumatology Abstract

 

CER13926
Free to view
11 click

A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
R. Spiera, D. Khanna, M. Kuwana, D.E. Furst, T.M. Frech, L. Hummers, W. Stevens, M. Matucci-Cerinic, M. Baron, O. Distler, N. Dgetluck, B.J. Bloom, Q. Dinh, B. White, C.P. Denton

Rheumatology Abstract

 

CER14362
Free to view
11 click

The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis
Y. Yoshizawa, T. Nakao, K. Tsuritani, T. Yamada, N. Watanabe, A. Chiba, W.H. Robinson, S. Miyake

Rheumatology Abstract

 

The 5 most viewed Abstract in the last 7 days
in press from 6 month ago (One year in review excluded)

From 21/11/2021 to 28/11/2021

CER12991
32 click

The association of different serum IgG4 levels with distinct clinical characteristics and treatment efficacy in patients with IgG4-related disease
P. Zhang, Z. Liu, J. Li, Y. Fei, X. Wang, M. Wang, L. Zhu, H. Xue, R. Feng, C. Hu, S. Zhang, W. Zhang, Y. Zhao, X. Zeng, F. Zhang

Rheumatology Abstract

 

CER14985
Free to view
24 click

Flare-up of adult-onset Still’s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota

Rheumatology Abstract

 

CER14837
Free to view
21 click

Apremilast for oral ulcers associated with active Behçet’s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici

Rheumatology Abstract

 

CER14676
Free to view
18 click

The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age
C. Specker, M. Aringer, G.-R. Burmester, B. Killy, M.W. Hofmann, H. Kellner, F. Moosig, H.-P. Tony, G. Fliedner

Rheumatology Abstract

 

CER14662
Free to view
16 click

The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still’s disease. A multicentre case-control study in China
H. Yao, Y. Wang, Z. Wang, J. Zhao, X. Deng, Z. Zhang, Y. Zhao, Y. Zhang, Q. Shu, Y. Jia, Z.-G. Li

Rheumatology Abstract